Research Update: Translating our knowledge of the DNA damage response into clinical benefits for patients with ovarian cancer
Led by Professor Richard Edmondson, this project set out to define the DNA damage response defects in high grade serous ovarian cancer (HGSOC) to predict patients' response to chemotherapy and the likelihood of recurrence.